Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramsay Health CareASX:RHC -0.23%86 EV-to-EBITDA is 11.42 as of Jul. 21, 2026, which is 17% below its 10-year median of 13.74. GuruFocus rates ASX:RHC with a GF Score™ of 86/100 and a GF Value™ of A$50.82 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 506 Healthcare Providers & Services companies, Ramsay Health Care ranks worse than 51.58% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ramsay Health Care's enterprise value is A$22,002 Mil.
Ramsay Health Care's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$1,927 Mil. Therefore, Ramsay Health Care's EV-to-EBITDA for today is 11.42.
The historical rank and industry rank for Ramsay Health Care's EV-to-EBITDA or its related term are showing as below:
ASX:RHC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.1 Med: 13.74 Max: 17.61
Current: 11.42
During the past 13 years, the highest EV-to-EBITDA of Ramsay Health Care was 17.61. The lowest was 10.10. And the median was 13.74.
ASX:RHC's EV-to-EBITDA is ranked worse than 51.58% of 506
companies
in the Healthcare Providers & Services industry
Industry Median: 11.1
vs ASX:RHC: 11.42
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Ramsay Health Care (ASX:RHC) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ramsay Health Care's PE Ratio (TTM) for today is calculated as:
Ramsay Health Care's share price for today is A$43.02.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ramsay Health Care's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$1.262.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Ramsay Health Care's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Ramsay Health Care's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramsay Health Care EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Health Care's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Ramsay Health Care's EV-to-EBITDA falls into.
Ramsay Health Care's current Enterprise Value is A$22,002 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ramsay Health Care's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$1,927 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramsay Health Care (ASX:RHC) has a EV-to-EBITDA of 11.42 as of Jul. 21, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ramsay Health Care. This is 17% below median its historical median of 13.74. Over the past decade, Ramsay Health Care's EV-to-EBITDA has ranged from 10.10 to 17.61. According to the industry distribution chart, Ramsay Health Care ranks #261 out of 506 companies in the Healthcare Providers & Services industry, placing it in the top 51.6%.
Is Ramsay Health Care's EV-to-EBITDA too high?
Ramsay Health Care's current EV-to-EBITDA of 11.42 is 17% below median its 10-year median of 13.74. Over the past 10 years, this metric has ranged from a low of 10.10 to a high of 17.61. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.10. Ramsay Health Care's value of 11.42 is 2.9% above this industry median. Based on the distribution chart, Ramsay Health Care ranks #261 out of 506 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ramsay Health Care has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ramsay Health Care's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramsay Health Care ranks #261 out of 506 companies for EV-to-EBITDA. This places Ramsay Health Care in the lower half of its industry. The industry median EV-to-EBITDA is 11.10. Ramsay Health Care's value of 11.42 is 2.9% above this benchmark. Historically, Ramsay Health Care's own EV-to-EBITDA has ranged from 10.10 to 17.61 over the past decade. While the company's 10-year median is 13.74 vs. the industry median of 11.10, Ramsay Health Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.10, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramsay Health Care's current EV-to-EBITDA of 11.42 is 2.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ramsay Health Care. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramsay Health Care's current EV-to-EBITDA is 11.42, which is 17% below median its own 10-year median of 13.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Health Care stock overvalued right now?
Based on GuruFocus' analysis, Ramsay Health Care (ASX:RHC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$50.82, compared to a current price of A$43.02 — trading 15.3% below its estimated fair value. The current EV-to-EBITDA is 11.42, which is 17% below median its 10-year median of 13.74 and 2.9% above the Healthcare Providers & Services industry median of 11.10. Ramsay Health Care's overall GF Score™ is 86/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Ramsay Health Care (ASX:RHC), the current EV-to-EBITDA is 11.42 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramsay Health Care (ASX:RHC) Overvalued in 2026?
Based on GuruFocus' analysis, Ramsay Health Care stock appears to be undervalued.
The current stock price of A$43.02 is trading 15.3% below its estimated GF Value™ of A$50.82.
GuruFocus considers Ramsay Health Care to be Modestly Undervalued.
Key valuation signals for ASX:RHC:
EV-to-EBITDA: 11.42 (17% below median its 10-year median of 13.74)
GF Value™: A$50.82 vs. price of A$43.02 (15.3% below fair value)
Industry Position: 2.9% above the Healthcare Providers & Services median (#261 of 506)
No single metric tells the full story. See the ASX:RHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramsay Health Care is one of the largest private healthcare providers in the world, with more than 500 sites across about eight countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK, where it is the largest independent supplier to the NHS. Ramsay Santé, which operates the European regions other than the UK, is a 53%-owned subsidiary of Ramsay Health Care. The company typically earns about two-thirds of consolidated earnings in Australia. Ramsay Health Care undertakes both private and publicly funded healthcare.
86GF Score
Get the complete analysis for ASX:RHC
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:RHC has been successfully added to your 
